Research peptides in Australia.

What are research peptides?

Research peptides are short chains of amino acids — typically 2 to 50 residues long — supplied to academic laboratories, independent researchers, and study facilities for pre-clinical and in-vitro investigation. They are not consumer products. They are not prescription medicines. They are not dietary supplements. They sit in a regulatory category specifically for laboratory research use, distinct from human therapeutic supply.

Peptides differ from larger proteins by sheer length: a peptide is short enough that its three-dimensional conformation is dominated by its primary sequence, where a protein has substantial secondary and tertiary structure. Biologically, peptides serve as signalling molecules — hormones, neuropeptides, growth factors — and the research peptide market exists because these signalling pathways are of significant scientific interest across metabolism, neurology, tissue repair, and longevity research.

How peptides are classified in Australia

The Australian regulatory landscape for peptides has four distinct categories, and conflating them is the most common source of confusion:

• Prescription medicines (S4): approved peptide drugs such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro) — supplied through pharmacies on valid prescription. These are not research peptides.
• Compounded medicines: prepared by a registered Australian pharmacy from an API for a named patient with a valid prescription. Compounded BPC-157, CJC-1295, and similar fall in this category when supplied for human use.
• Research compounds: supplied for laboratory and pre-clinical study without therapeutic claims and not for human consumption. This is the category Quantum Labs operates in.
• Cosmetic compounds: copper peptides (GHK-Cu) and similar appear in cosmetic products for skin appearance. Cosmetic supply is regulated separately from therapeutic supply.

The TGA enforces the boundary between these categories primarily through claims and intended use. A compound supplied with no therapeutic claims, for research use only, is regulated differently to the same molecule marketed for human treatment.

Purity standards that matter

Research outcomes are only as reliable as the compounds that produce them. A peptide labelled “95% pure” contains up to 5% impurities — fragments from incomplete synthesis, deletion peptides, racemised residues. In a research context those impurities are noise that can obscure real effects, or worse, produce artefacts that read as real findings.

Three things to look for when sourcing research peptides:

• HPLC purity ≥99% — verified by high-performance liquid chromatography. This is the standard purity assay for synthetic peptides and the floor for research-grade material.
• Identity by mass spectrometry — confirms the compound supplied is the compound on the label, not a deletion or substitution product. Especially important for longer sequences where synthesis errors compound.
• Third-party testing — certificates of analysis from labs outside the supplier's own facility. In-house testing alone has obvious conflict of interest issues.

Every Quantum Labs compound meets all three. Batch-level certificates of analysis are available on request.

Compounds we supply

We carry a curated catalogue of research-grade peptides covering metabolic, recovery, neurological, longevity, and dermal-research applications. Every compound below is supplied for research use only and ships from Australian stock.

• BPC-157 — Tissue repair research peptide
• TB-500 — Actin-binding research peptide
• BPC-157 + TB-500 — Recovery research stack
• GHK-Cu — Copper peptide research complex
• CJC-1295 + Ipamorelin — GHRH + ghrelin mimetic stack
• Semax — Nootropic research heptapeptide
• Selank — Anxiolytic research peptide
• PT-141 — Bremelanotide melanocortin agonist
• MOTS-c — Mitochondrial-derived metabolic peptide
• Tesamorelin — Stabilised GHRH analogue
• Epithalon — Telomerase research tetrapeptide
• SS-31 — Mitochondria-targeted research peptide
• DSIP — Delta sleep-inducing peptide
• 5-Amino-1MQ — NNMT inhibitor research compound
• AOD 9604 — HGH fragment research peptide
• NAD+ — Cellular redox cofactor
• Glutathione — Antioxidant research peptide
• L-Carnitine — Mitochondrial fatty-acid transporter
• Retatrutide — Tri-agonist research peptide
• Bacteriostatic Water — Research peptide reconstitution supplies

Not sure which compound matches your research focus? Take the protocol quiz — five questions narrow the catalogue to the compounds most relevant to your research goals.

Ordering, payment, and shipping

Orders are placed through the catalogue and paid in cryptocurrency via NOWPayments — Bitcoin, Ethereum, Solana, USDT, USDC. Payment confirmation triggers dispatch from Australian stock, typically within 24 hours. Standard domestic shipping arrives in 2-5 business days depending on state.

All compounds are dispatched in sealed lyophilised vials with batch identifiers traceable to the originating certificate of analysis. We do not ship outside Australia.

Frequently asked questions